Progressive familial intrahepatic cholestasis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 6, 1999, Pages 594-599

  Jacquemin, Emmanuel ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Biliary diversion; Byler disease; Children; Genetic cholestasis; Ursodeoxycholic acid

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BILE ACID METABOLISM; BILE SECRETION; CELL HETEROGENEITY; CHILD; CHILDHOOD DISEASE; GENE MUTATION; GENE THERAPY; HUMAN; INFANT; INTRAHEPATIC CHOLESTASIS; LIVER CELL; LIVER FAILURE; LIVER TRANSPLANTATION; NEWBORN; NEWBORN PERIOD; ORAL DRUG ADMINISTRATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

EID: 0033013690     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01921.x     Document Type: Article

References (32)

1. 1 Clayton RJ, Iber FI, Ruebner BH et al. Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred. Am. J. Dis. Child. 1969; 117: 112-24.
2. 2 Maggiore G, Bernard O, Riely C et al. Normal serum γ-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J. Pediatr. 1987; 111: 251-2.
3. 3 Whitington PF, Freese DK, Alonso EM et al. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J. Pediatr. Gastroenterol. Nutr. 1994; 18: 134-41.
4. 4 Jacquemin E, Dumont M, Bernard O et al. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur. J. Pediatr. 1994; 153: 424-8.
5. 27-steroid dehydrogenase/isomerase deficiency. J. Pediatr. 1994; 125: 379-84.
6. 6 Carlton V, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum. Mol. Genet. 1995; 4: 1049-53.
7. 7 Strautnieks SS, Kagalwalla AF, Tanner MS et al. Identification of a locus for progressive familial intrahepatic cholestasis (PFIC2) on chromosome 2q24. Am. J. Hum. Genet. 1997; 61: 630-3.
8. 8 Bull LN, Van Eijk MJT, Pawlikowska L et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat. Genet. 1998; 18: 219-24.
9. 9 Jansen P, Hooiveld G, Jacquemin E et al. The canalicular bile salt exporting protein BSEP is not expressed in patients with progressive familial intrahepatic cholestasis type 2. Hepatology 1998; 28: 498A.
10. 10 De Vree JML, Jacquemin E, Sturm E et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl Acad. Sci. USA 1998; 95: 282-7.
11. 11 Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N. Engl. J. Med. 1998; 339: 1217-27.
12. 12 Gerloff T, Stieger B, Hagenbuch B et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J. Biol. Chem. 1998; 273: 10046-50.
13. 13 Strautnieks SS, Bull LN, Knisely AS et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 1998; 20: 233-8.
14. 14 Smit JJM, Shinkel AH, Oude Elferink RPJ et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-62.
15. 15 Smith AJ, Timmermans-Hereijgers JLPM, Roelofsen B et al. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 1994; 354: 263-6.
16. 16 Reutz S, Gros P. Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell 1994; 77: 1071-81.
17. 17 Smit JJM, Shinkel AH, Mol CAAM et al. Tissue distribution of the human MDR3 P-glycoprotein. Lab. Invest. 1994; 71; 638-49.
18. 18 Lincke CR, Smit JJM, Van Der Velde-KoertsT et al. Structure of the human MDR3 gene and physical mapping of the human MDR locus. J. Biol. Chem. 1991; 266: 5303-10.
19. 19 Smith AJ, De Vree JML, Ottenhoff R et al. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice. Hepatology 1998; 28: 530-6.
20. 20 Deleuze JF, Jacquemin E, Dubuisson C et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904-8.
21. 21 Jaequemin E, De Vree JML, Cresteil D et al. MDR3 deficiency: Progressive familial intrahepatic cholestasis (PFIC) due to MDR3 gene mutations. Hepatology 1998; 28: 316A.
22. 22 Jacquemin E, Hermans D, Myara A et al. Ursodeoxycholic therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997; 25: 519-23.
23. 23 Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 1988; 95: 130-6.
24. 24 Emond JC, Whitington PF. Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease). J. Pediatr. Surg. 1995; 30: 1635-41.
25. 25 Poupon RE, Chretien Y, Poupon R et al. Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy. Hepatology 1993; 17: 599-604.
26. 26 Jacquemin E, Dumont M, Erlinger S. Ursodeoxycholic acid improves ethinyl estradiol induced-cholestasis in the rat. Eur. J. Clin. Invest. 1993; 23: 794-802.
27. 4+, mechanisms defective in cholestasis. J. Clin. Invest. 1993; 93: 2984-93.
28. 28 Palma J, Reyes H, Ribalta J et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15: 1043-7.
29. 29 van Nieuwkerk CJM, Oude Elferink RPJ, Groen AK et al. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996; 111: 165-71.
30. 30 Soubrane O, Gauthier F, Devictor D et al. Orthotopic liver transplantation for Byler disease. Transplantation 1990; 50: 804-6.
31. 31 de Vree JML, Ottenhof R, Smith AJ et al. Rapid correction of mdr2 deficiency by transplantation of MDR3 transgenic hepatocytes. Hepatology 1998, 28: 387A.
32. 32 Holzbach RT, Kibe A, Thiel E, Howell JH, Marsh M, Hermann RE. Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J. Clin. Invest. 1984; 73: 35-45.